Area of research
Genetics · Hematology
Research interest
Research interests include Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Lymphoma Diagnosis and Treatment, and Acute Lymphoblastic Leukemia research.
MALT1 inhibitor suppresses AML by inducing MCPIP1 expression and shows synergy with venetoclax
Upregulation of ROBO3 promotes proliferation, migration and adhesion of AML cells and affects the survival of AML patients
SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling
A multi-center, open-label, randomized, parallel-controlled phase II study comparing pharmacokinetic, pharmacodynamics and safety of ripertamab (SCT400) to rituximab (MabThera� in patients with CD20-positive B-cell non-Hodgkin lymphoma
Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony-Stimulating Factor (CDCAG) in Patients with Relapsed/Refractory Acute Myeloid Leukaemia: A Single-Arm, Phase 1/2 Study